Matches in SemOpenAlex for { <https://semopenalex.org/work/W3097304805> ?p ?o ?g. }
- W3097304805 endingPage "1735" @default.
- W3097304805 startingPage "1724" @default.
- W3097304805 abstract "Parkinson disease (PD) is highly prevalent among neurodegenerative diseases, affecting a diverse patient population. Despite a general willingness of patients to participate in clinical trials, only a subset of patients enroll in them. Understanding the barriers to trial participation will help to alleviate this discrepancy and improve trial participation. Underrepresented minorities, older patients, and patients with more medical comorbidities in particular are underrepresented in research. In clinical trials, this has the effect of delaying trial completion, exacerbating disparities, and limiting our ability to generalize study results. Efforts to improve trial design and recruitment are necessary to ensure study enrollment reflects the diversity of patients with PD. At the trial design level, broadening inclusion criteria, attending to participant burden, and focusing on trial efficiency may help. At the recruitment stage, increasing awareness, with traditional outreach or digital approaches; improving engagement, particularly with community physicians; and developing targeted recruitment efforts can also help improve enrollment of underrepresented patient groups. The use of technology, for virtual visits, technology-based objective measures, and community engagement, can also reduce participant burden and increase recruitment. By designing trials to consider these barriers to trial participation, we can improve not only the access to research for all our patients but also the quality and generalizability of clinical research in PD." @default.
- W3097304805 created "2020-11-09" @default.
- W3097304805 creator A5029739306 @default.
- W3097304805 creator A5060336923 @default.
- W3097304805 creator A5083598511 @default.
- W3097304805 date "2020-10-01" @default.
- W3097304805 modified "2023-10-16" @default.
- W3097304805 title "Overcoming Barriers to Parkinson Disease Trial Participation: Increasing Diversity and Novel Designs for Recruitment and Retention" @default.
- W3097304805 cites W1479935944 @default.
- W3097304805 cites W1493115321 @default.
- W3097304805 cites W1495377470 @default.
- W3097304805 cites W1805169257 @default.
- W3097304805 cites W1841373314 @default.
- W3097304805 cites W1919842320 @default.
- W3097304805 cites W194509905 @default.
- W3097304805 cites W1964181036 @default.
- W3097304805 cites W1964486086 @default.
- W3097304805 cites W1975572911 @default.
- W3097304805 cites W1976092863 @default.
- W3097304805 cites W1976676734 @default.
- W3097304805 cites W1983117789 @default.
- W3097304805 cites W1984114172 @default.
- W3097304805 cites W1984359064 @default.
- W3097304805 cites W1987467897 @default.
- W3097304805 cites W1987855626 @default.
- W3097304805 cites W1988266165 @default.
- W3097304805 cites W1990305379 @default.
- W3097304805 cites W2017675004 @default.
- W3097304805 cites W2027216315 @default.
- W3097304805 cites W2039865683 @default.
- W3097304805 cites W2043254260 @default.
- W3097304805 cites W2046690778 @default.
- W3097304805 cites W2053329970 @default.
- W3097304805 cites W2054010962 @default.
- W3097304805 cites W2058190976 @default.
- W3097304805 cites W2064546274 @default.
- W3097304805 cites W2065868932 @default.
- W3097304805 cites W2066761309 @default.
- W3097304805 cites W2067236407 @default.
- W3097304805 cites W2075765029 @default.
- W3097304805 cites W2087164876 @default.
- W3097304805 cites W2092510013 @default.
- W3097304805 cites W2096037956 @default.
- W3097304805 cites W2096682568 @default.
- W3097304805 cites W2099481242 @default.
- W3097304805 cites W2101345641 @default.
- W3097304805 cites W2108890677 @default.
- W3097304805 cites W2108901766 @default.
- W3097304805 cites W2111958433 @default.
- W3097304805 cites W2112765817 @default.
- W3097304805 cites W2117057382 @default.
- W3097304805 cites W2117439529 @default.
- W3097304805 cites W2119678836 @default.
- W3097304805 cites W2120704617 @default.
- W3097304805 cites W2126160304 @default.
- W3097304805 cites W2127561989 @default.
- W3097304805 cites W2127571714 @default.
- W3097304805 cites W2130332503 @default.
- W3097304805 cites W2131866252 @default.
- W3097304805 cites W2141123937 @default.
- W3097304805 cites W2148889369 @default.
- W3097304805 cites W2150229987 @default.
- W3097304805 cites W2150748627 @default.
- W3097304805 cites W2171913066 @default.
- W3097304805 cites W2185515204 @default.
- W3097304805 cites W2214259081 @default.
- W3097304805 cites W2226419169 @default.
- W3097304805 cites W2255303688 @default.
- W3097304805 cites W2328956903 @default.
- W3097304805 cites W2335990176 @default.
- W3097304805 cites W2340835891 @default.
- W3097304805 cites W2400321552 @default.
- W3097304805 cites W2462016537 @default.
- W3097304805 cites W2468673334 @default.
- W3097304805 cites W2534600101 @default.
- W3097304805 cites W2550133290 @default.
- W3097304805 cites W259184059 @default.
- W3097304805 cites W2598516989 @default.
- W3097304805 cites W2602335128 @default.
- W3097304805 cites W2604979397 @default.
- W3097304805 cites W2607139442 @default.
- W3097304805 cites W2616393094 @default.
- W3097304805 cites W2738137475 @default.
- W3097304805 cites W2763133656 @default.
- W3097304805 cites W2765393333 @default.
- W3097304805 cites W2775131913 @default.
- W3097304805 cites W2778801047 @default.
- W3097304805 cites W2791498037 @default.
- W3097304805 cites W2791818301 @default.
- W3097304805 cites W2794398882 @default.
- W3097304805 cites W2794848061 @default.
- W3097304805 cites W2803076325 @default.
- W3097304805 cites W2807451695 @default.
- W3097304805 cites W2811255424 @default.
- W3097304805 cites W2884514521 @default.
- W3097304805 cites W2892103738 @default.
- W3097304805 cites W2895194501 @default.
- W3097304805 cites W2896442240 @default.